Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 4 newly-hired employees options to purchase an aggregate of 76,000 shares of Akebia's common stock on May 31,.
Akebia Therapeutics, Inc (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Akebia to Host Conference Call on May 9, 2024, at 8:00 a.m. ET
CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ Akebia Therapeutics®, Inc. today announced plans to release its financial results for.
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.